news roundup
Updated employee announcements, business news, awards, and recognition in the industry today.
Advertisement
How clean is your clinical trial data?
A large group of clinical data management professionals were surveyed and 58% were not confident in the quality and completeness of their clinical data from an audit/compliance perspective. This is a brand new, in-depth report on Challenges and Opportunities in Clinical Data Management, conducted by Pharma Intelligence and sponsored by Oracle Health Sciences. Click here now to download the free survey report. |
PAREXEL, a provider of global biopharmaceutical services, announced that it has developed patient-centric solutions built on its Perceptive Cloud platform to leverage mobile and wearable technology.
Advertisement
Outcomes in Focus: Best Practices for eCOA
This eBook covers considerations and practical advice for smooth eCOA implementation; secrets to eCOA success from industry insiders; and new opportunities for the use of eCOA in clinical trials. Download Your Free eBook |
A cancer clinical research center has signed a $3.5 million commitment to OmniComm Systems, Inc., a global provider of clinical data management technology, to use its TrialMaster EDC to develop patient-centric cancer therapies.
Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT
Register Now |
Veeva Systems introduced its first application specifically built for clinical research centers, Veeva Vault SiteDocs. The new application is designed for sites to manage regulatory documentation and trial information and to streamline study activities.
Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
Europe: Thursday, November 8, 2018 at 3pm GMT | 4pm CET
Register Now |
|
|
|
Advertisement
Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now |
Advertisement
IDENTIFYING NASH PATIENTS: Solutions and Strategies
Thursday, November 1, 2018 at 11am EDT
Register Now |
Advertisement
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand
Learn More |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
Advertisement
Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
On Demand
Learn More |
|
Articles
For sponsors who are pursuing the goal of treating Alzheimer's disease, understanding the obstacles inherent in Alzheimer's clinical trials can help in planning for, and overcoming, these challenges.
|
Advertisement
Artificial Intelligence: A Transformative Journey for Pharmacovigilance
On Demand
Learn More |
|
Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
|
Advertisement
Challenging the Status Quo: The Diffusion of Technology in Study Startup
On Demand
Learn more |
|
Blog Posts
AMPLEXOR's Dana Weiss explains the critical role of linguistic validation in enabling the patients voice.
In this interview, Michael J. Graziano, PhD, DABT, Vice-President, Drug Safety Evaluation for Bristol-Myers Squibb and leader of the BioCelerate Toxicology Data Sharing Initiative, provides more details about the DataCelerate platform.
|
|
RBM
The results of a 2018 survey of sponsor, CRO, and technology companies.
A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|